NASDAQ: PIIIP3 Health Partners Inc Stock
$0.51+0.01 (+2%)
Updated Apr 19, 2024
PIII Price
$0.51
Fair Value Price
$1.06
Market Cap
$159.85M
52 Week Low
$0.45
52 Week High
$5.56
P/E
-0.83x
P/B
1.12x
P/S
0.11x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.27B
Earnings
-$57.77M
Gross Margin
3.5%
Operating Margin
-3.09%
Profit Margin
-4.6%
Debt to Equity
3.01
Operating Cash Flow
-$76M
Beta
0.79
Next Earnings
May 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A
PIII Overview
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PIII scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PIII ($0.51) is undervalued by 52.41% relative to our estimate of its Fair Value price of $1.06 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PIII ($0.51) is significantly undervalued by 52.41% relative to our estimate of its Fair Value price of $1.06 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
PIII is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PIII due diligence checks available for Premium users.
Be the first to know about important PIII news, forecast changes, insider trades & much more!
PIII News
Valuation
PIII fair value
Fair Value of PIII stock based on Discounted Cash Flow (DCF)
Price
$0.51
Fair Value
$1.06
Undervalued by
52.03%
PIII ($0.51) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PIII ($0.51) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PIII is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
PIII price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.83x
Industry
-2.45x
Market
40.51x
PIII price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.12x
Industry
4.44x
PIII is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PIII's financial health
Profit margin
Revenue
$346.9M
Net Income
-$25.5M
Profit Margin
-7.3%
PIII's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PIII's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$861.0M
Liabilities
$427.3M
Debt to equity
3.01
PIII's short-term liabilities ($299.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PIII's short-term assets ($166.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PIII's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$15.9M
Investing
$212.0k
Financing
-$840.0k
PIII's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PIII vs Medical Care Facility Stocks
P3 Health Partners Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.